This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ABRYSVO VIAL WITH DILUENT SYRGS, a pharmaceutical product, with a ceiling value of $8,714.52 and a completion date of June 6, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product, with a ceiling value of $8,004.80. The contract has a firm fixed price pricing type and an ultimate completion date of May 1, 2025. The contract is not set aside and is considered an open competition award. AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of "ABRYSVO VIAL WITH DILUENTS" medical products. The contract has a total ceiling value of $8,657.20 and a completion date of July 17, 2024. It is a firm fixed-price contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its larger Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ABRYSVO VIAL WITH DILUENT SYRGS, a pharmaceutical product, with a ceiling value of $4,802.88 and a period of performance through April 30, 2025. The contract is a firm fixed-price delivery order, and it is not set-aside. Amerisourcebergen Drug Corp is the prime contractor, and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product, with an ultimate completion date of November 25, 2024 and a ceiling value of $42,723.83. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract, valued at $12,095.55, is for the supply of ABRYSVO VIAL WITH DILUENT SYRGS, a pharmaceutical product. The contract has a performance period through September 30, 2024 and is a firm fixed price arrangement. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medical products and supplies to support...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the supply of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product, under a firm fixed-price contract with a ceiling value of $34,628.80. The contract has an ultimate completion date of September 20, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of "ABRYSVO VIAL WITH DILUENT SYRGS" with a ceiling value of $2,160.60 and a completion date of May 16, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,684.99 firm-fixed-price contract is for the provision of ABRYSVO VIAL WITH DILUENTS, a medical product. The contract has an ultimate completion date of January 18, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ABRYSVO VIAL WITH DILUENT SYRGS, with a ceiling value of $6,403.84 and a completion date of February 25, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...